{"entity":{"type":"insider","cik":"0001385496","url":"/insider/0001385496","json_url":"/insider/0001385496.json","name":"Stonehouse Jon P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":22,"first":"2007-08-02","last":"2024-05-15","span_basis":"filed_date"},"name_variants":[{"name":"Stonehouse Jon P","source":"filing","n_filings":22,"first_seen":"2007-08-02","last_seen":"2024-05-15"}],"transactions":[{"id":2109729,"accession":"0001127602-24-015365","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-015365","line_url":"/filing/0001127602-24-015365#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":5.55,"price_display":"5.55","price_state":"stated","total_value":166500.0,"total_display":"166,500.00","total_whole":"166,500","shares_owned_after":1127770.0,"shares_owned_after_display":"1,127,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-13","filed_date":"2024-05-15","scope":"insider"},{"id":8759455,"accession":"0001127602-23-003172","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-23-003172","line_url":"/filing/0001127602-23-003172#line-5","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":10.38,"price_display":"10.38","price_state":"stated","total_value":1038000.0,"total_display":"1,038,000.00","total_whole":"1,038,000","shares_owned_after":1008739.0,"shares_owned_after_display":"1,008,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-02","scope":"insider"},{"id":6638969,"accession":"0001127602-22-027894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-027894","line_url":"/filing/0001127602-22-027894#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14100.0,"shares_display":"14,100","price_per_share":10.9,"price_display":"10.90","price_state":"stated","total_value":153690.0,"total_display":"153,690.00","total_whole":"153,690","shares_owned_after":887730.0,"shares_owned_after_display":"887,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-19","scope":"insider"},{"id":6720681,"accession":"0001127602-22-026832","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-22-026832","line_url":"/filing/0001127602-22-026832#line-4","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82656.0,"shares_display":"82,656","price_per_share":12.8,"price_display":"12.80","price_state":"stated","total_value":1057996.8,"total_display":"1,057,996.80","total_whole":"1,057,997","shares_owned_after":901830.0,"shares_owned_after_display":"901,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-02","scope":"insider"},{"id":6720676,"accession":"0001127602-22-026832","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-026832","line_url":"/filing/0001127602-22-026832#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":214917.0,"shares_display":"214,917","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":2793921.0,"total_display":"2,793,921.00","total_whole":"2,793,921","shares_owned_after":901830.0,"shares_owned_after_display":"901,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-02","scope":"insider"},{"id":6961996,"accession":"0001127602-22-001458","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-001458","line_url":"/filing/0001127602-22-001458#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":184000.0,"shares_display":"184,000","price_per_share":15.04,"price_display":"15.04","price_state":"stated","total_value":2767360.0,"total_display":"2,767,360.00","total_whole":"2,767,360","shares_owned_after":901602.0,"shares_owned_after_display":"901,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-01-13","scope":"insider"},{"id":2149425,"accession":"0001127602-20-031780","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-031780","line_url":"/filing/0001127602-20-031780#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":134278.0,"shares_display":"134,278","price_per_share":8.32,"price_display":"8.32","price_state":"stated","total_value":1117192.96,"total_display":"1,117,192.96","total_whole":"1,117,193","shares_owned_after":784086.0,"shares_owned_after_display":"784,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-17","scope":"insider"},{"id":8523203,"accession":"0001127602-19-033035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-19-033035","line_url":"/filing/0001127602-19-033035#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":72500.0,"total_display":"72,500.00","total_whole":"72,500","shares_owned_after":778086.0,"shares_owned_after_display":"778,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-18","scope":"insider"},{"id":6074130,"accession":"0001127602-18-035394","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-035394","line_url":"/filing/0001127602-18-035394#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":9.12,"price_display":"9.12","price_state":"stated","total_value":729600.0,"total_display":"729,600.00","total_whole":"729,600","shares_owned_after":727674.0,"shares_owned_after_display":"727,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider"},{"id":6086033,"accession":"0001358403-18-000102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001358403-18-000102","line_url":"/filing/0001358403-18-000102#line-1","is_derivative":false,"issuer_cik":"0001358403","issuer_name":"BELLICUM PHARMACEUTICALS, INC","issuer_ticker":"BLCM","issuer_name_source":null,"issuer_url":"/issuer/0001358403","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.56,"price_display":"4.56","price_state":"stated","total_value":45600.0,"total_display":"45,600.00","total_whole":"45,600","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-09","filed_date":"2018-11-13","scope":"insider"},{"id":8749404,"accession":"0001127602-15-021137","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-15-021137","line_url":"/filing/0001127602-15-021137#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":15.02,"price_display":"15.02","price_state":"stated","total_value":300400.0,"total_display":"300,400.00","total_whole":"300,400","shares_owned_after":650869.0,"shares_owned_after_display":"650,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-19","filed_date":"2015-06-22","scope":"insider"},{"id":2666195,"accession":"0001127602-12-009583","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-009583","line_url":"/filing/0001127602-12-009583#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2721.0,"shares_display":"2,721","price_per_share":4.78,"price_display":"4.78","price_state":"stated","total_value":13006.38,"total_display":"13,006.38","total_whole":"13,006","shares_owned_after":239384.0,"shares_owned_after_display":"239,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-02","filed_date":"2012-03-05","scope":"insider"},{"id":8828657,"accession":"0001127602-11-023086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-11-023086","line_url":"/filing/0001127602-11-023086#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.519,"price_display":"2.52","price_state":"stated","total_value":25190.0,"total_display":"25,190.00","total_whole":"25,190","shares_owned_after":217492.0,"shares_owned_after_display":"217,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-08","filed_date":"2011-08-09","scope":"insider"},{"id":8846918,"accession":"0001127602-11-010718","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-11-010718","line_url":"/filing/0001127602-11-010718#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.3988,"price_display":"3.40","price_state":"stated","total_value":33988.0,"total_display":"33,988.00","total_whole":"33,988","shares_owned_after":194180.0,"shares_owned_after_display":"194,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-18","filed_date":"2011-03-18","scope":"insider"},{"id":5911936,"accession":"0001127602-09-002348","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-09-002348","line_url":"/filing/0001127602-09-002348#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.615,"price_display":"1.62","price_state":"stated","total_value":4845.0,"total_display":"4,845.00","total_whole":"4,845","shares_owned_after":103603.0,"shares_owned_after_display":"103,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-30","filed_date":"2009-02-03","scope":"insider"},{"id":3516578,"accession":"0000882796-08-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000882796-08-000041","line_url":"/filing/0000882796-08-000041#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55000.0,"shares_display":"55,000","price_per_share":1.4809,"price_display":"1.48","price_state":"stated","total_value":81449.5,"total_display":"81,449.50","total_whole":"81,450","shares_owned_after":155603.0,"shares_owned_after_display":"155,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-01","filed_date":"2008-12-02","scope":"insider"},{"id":3812439,"accession":"0000882796-08-000039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000882796-08-000039","line_url":"/filing/0000882796-08-000039","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.74916,"price_display":"1.75","price_state":"stated","total_value":43729.0,"total_display":"43,729.00","total_whole":"43,729","shares_owned_after":100603.0,"shares_owned_after_display":"100,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-03","filed_date":"2008-11-03","scope":"insider","n_lines":2},{"id":3693340,"accession":"0000882796-08-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000882796-08-000037","line_url":"/filing/0000882796-08-000037#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2300.0,"shares_display":"2,300","price_per_share":3.0975,"price_display":"3.10","price_state":"stated","total_value":7124.25,"total_display":"7,124.25","total_whole":"7,124","shares_owned_after":75603.0,"shares_owned_after_display":"75,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-12","filed_date":"2008-08-13","scope":"insider"},{"id":3639163,"accession":"0000882796-08-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000882796-08-000035","line_url":"/filing/0000882796-08-000035#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7700.0,"shares_display":"7,700","price_per_share":2.9527,"price_display":"2.95","price_state":"stated","total_value":22735.79,"total_display":"22,735.79","total_whole":"22,736","shares_owned_after":73303.0,"shares_owned_after_display":"73,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-11","filed_date":"2008-08-13","scope":"insider"},{"id":3559675,"accession":"0000882796-08-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000882796-08-000031","line_url":"/filing/0000882796-08-000031#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":240.0,"shares_display":"240","price_per_share":2.822,"price_display":"2.82","price_state":"stated","total_value":677.28,"total_display":"677.28","total_whole":"677","shares_owned_after":65603.0,"shares_owned_after_display":"65,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-04","filed_date":"2008-08-04","scope":"insider"},{"id":3869521,"accession":"0000882796-08-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000882796-08-000004","line_url":"/filing/0000882796-08-000004#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.502,"price_display":"3.50","price_state":"stated","total_value":10506.0,"total_display":"10,506.00","total_whole":"10,506","shares_owned_after":65363.0,"shares_owned_after_display":"65,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-31","filed_date":"2008-02-04","scope":"insider"},{"id":7056100,"accession":"0000882796-07-000054","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000882796-07-000054","line_url":"/filing/0000882796-07-000054#line-8","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2650.0,"shares_display":"2,650","price_per_share":9.86,"price_display":"9.86","price_state":"stated","total_value":26129.0,"total_display":"26,129.00","total_whole":"26,129","shares_owned_after":62363.0,"shares_owned_after_display":"62,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-14","filed_date":"2007-08-14","scope":"insider"},{"id":7056098,"accession":"0000882796-07-000054","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000882796-07-000054","line_url":"/filing/0000882796-07-000054","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7250.0,"shares_display":"7,250","price_per_share":9.91215448275862,"price_display":"9.91","price_state":"stated","total_value":71863.12,"total_display":"71,863.12","total_whole":"71,863","shares_owned_after":59713.0,"shares_owned_after_display":"59,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-13","filed_date":"2007-08-14","scope":"insider","n_lines":7},{"id":8442208,"accession":"0000882796-07-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000882796-07-000050","line_url":"/filing/0000882796-07-000050#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001385496","owner_name":"Stonehouse Jon P","owner_display_name":"Stonehouse Jon P","owner_url":"/insider/0001385496","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2463.0,"shares_display":"2,463","price_per_share":7.055,"price_display":"7.06","price_state":"stated","total_value":17376.465,"total_display":"17,376.46","total_whole":"17,376","shares_owned_after":52463.0,"shares_owned_after_display":"52,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-31","filed_date":"2007-08-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":22,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000882796","name":"BIOCRYST PHARMACEUTICALS INC","url":"/issuer/0000882796","role":"Director, Officer (President & CEO)","n_filings":21,"first_seen":"2007-08-02","last_seen":"2024-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001358403","name":"BELLICUM PHARMACEUTICALS, INC","url":"/issuer/0001358403","role":"Director","n_filings":1,"first_seen":"2018-11-13","last_seen":"2018-11-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001385496","retrieved_at":"2026-08-22T14:38:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}